Off-label use of drugs and medical devices: a review of policy implications

Clinical Pharmacology & Therapeutics, 04/13/2012

Given the contradictory and unresolved expectations of major stakeholders, off–label use remains problematic. It requires a new policy paradigm that can successfully balance the need for innovation against the imperatives of evidence–based practice and finite health–care resources.

Print Article Summary Cat 2 CME Report